Exchange: NASDAQ·Updated 07:30 PM EST

About PTGX

About

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
132

Frequently Asked Questions

Advertisement|Remove ads.